Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Teclistamab As Consolidation in the First-line Treatment of Patients with Newly Diagnosed Multiple Myeloma.

NCT06758375 is registered in ClinicalTrials.gov with Hospital Universitario Dr. Jose E. Gonzalez as lead sponsor.

NCT NCT06758375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06758375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Teclistamab As Consolidation in the First-line Treatment of Patients with Newly Diagnosed Multiple Myeloma.
Lead sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Phase
Phase 2
Overall status
Recruiting
Start date
March 3, 2025
Completion date
December 1, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, newly diagnosed